Skip to Main content Skip to Navigation
Journal articles

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

Juliana Inoue 1 Miguel Silva 2 Bakary Fofana 3 Kassim Sanogo 3 Andreas Mårtensson 1 Issaka Sagara 3 Anders Bjorkman 4 Maria Isabel Veiga 2 Pedro Eduardo Ferreira 2 Abdoulaye Djimde 3 José Pedro Gil 1, 4, 5
1 Uppsala University
2 Instituto de Ingeniería [Mexico]
3 University of Science, Techniques, and Technologies [Bamako, Mali]
4 Karolinska Institutet [Stockholm, Sweden]
5 ULISBOA - Universidade de Lisboa
Abstract : Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.
Keywords : DHA-PPQ Pfpm2 Plasmodium falciparum West Africa dihydroartemisinin-piperaquine malaria moquitoborne diseases piperaquine plasmepsin 2 resistance vector-borne infections
Document type :
Journal articles
Complete list of metadata

Cited literature [20 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02093060
Contributor : Christine Dupuis <>
Submitted on : Monday, April 8, 2019 - 4:06:33 PM
Last modification on : Tuesday, December 15, 2020 - 3:56:02 PM
Long-term archiving on: : Tuesday, July 9, 2019 - 5:14:55 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

INSERM

Citation

Juliana Inoue, Miguel Silva, Bakary Fofana, Kassim Sanogo, Andreas Mårtensson, et al.. Plasmodium falciparum Plasmepsin 2 Duplications, West Africa. Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2018, 24 (8), pp.1591-1593. ⟨10.3201/eid2408.180370⟩. ⟨inserm-02093060⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

77